Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Non-cash Items: 2017-2024

Historic Non-cash Items for Viking Therapeutics (VKTX) over the last 8 years, with Dec 2024 value amounting to $1.9 million.

  • Viking Therapeutics' Non-cash Items rose 47.85% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 47.85%. This contributed to the annual value of $1.9 million for FY2024, which is 24.52% down from last year.
  • According to the latest figures from FY2024, Viking Therapeutics' Non-cash Items is $1.9 million, which was down 24.52% from $2.5 million recorded in FY2023.
  • Viking Therapeutics' Non-cash Items' 5-year high stood at $20.5 million during FY2022, with a 5-year trough of $1.8 million in FY2020.
  • Over the past 3 years, Viking Therapeutics' median Non-cash Items value was $2.5 million (recorded in 2023), while the average stood at $8.3 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 811.11% in 2022, then plummeted by 87.95% in 2023.
  • Over the past 5 years, Viking Therapeutics' Non-cash Items (Yearly) stood at $1.8 million in 2020, then climbed by 25.98% to $2.3 million in 2021, then spiked by 811.11% to $20.5 million in 2022, then slumped by 87.95% to $2.5 million in 2023, then dropped by 24.52% to $1.9 million in 2024.